Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
Carmell Therapeutics Carmell Therapeutics (US:CTCX) Newsfilter·2024-07-29 12:30

Core Insights - Carmell Corporation has appointed Ms. Kendra Bracken-Ferguson as CEO effective July 30, 2024, while Mr. Rajiv Shukla continues as Executive Chairman [1][2] Company Developments - The appointment of Kendra Bracken-Ferguson comes during a significant growth phase for the company, which has pivoted towards skincare since its business combination in July 2023 [2] - The company has developed and tested 12 skincare products aimed at retail and medspa use, scaled up in-house manufacturing, and lowered cash burn by over 50% [2] - Carmell raised $3 million from external investors and commenced commercial sales, and was added to the Russell Microcap Index in June 2024 [2] Leadership Background - Kendra Bracken-Ferguson has over 20 years of experience in the beauty and wellness industry, having held senior leadership roles and co-founding influential companies [6] - She has partnered with notable brands and sits on various advisory councils, showcasing her extensive network and expertise in brand building and digital marketing [3][6] Strategic Vision - Under Kendra's leadership, Carmell aims to accelerate the growth of its flagship brand, Carmell Secretome™, and expand its portfolio through strategic investments and acquisitions [6][7] - The company focuses on technology and product innovation, emphasizing customer relationships and brand building as key drivers for future growth [4]

Carmell Therapeutics -Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index - Reportify